Quality of life and neurocognitive function are important clinical outcome measures for patients with lower grade glioma. In this pilot study, we performed neurocognitive testing and quality of life assessments in radiologically and clinically stable grade II and III glioma patients who were not receiving active treatment. We found novel associations between standard clinical assessments and neuroimaging metrics at pre-surgical and follow-up timepoints. Further characterizing the longitudinal relationship between structural and functional neuroimaging, neurocognition and quality of life will better allow clinicians to proactively intervene to help patients in future.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords